がん免疫療法による結腸炎の分子経路
Adrienne M Luoma1, Shengbao Suo2, Hannah L Williams3
1Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Immunology, Harvard Medical School, Boston, MA 02115, USA.
Cell
|July 1, 2020
まとめ
チェックポイント阻害免疫療法は 大腸炎のような 深刻な炎症的副作用を引き起こします この研究は,細胞毒性CD8T細胞が組織在住集団から発生し,これらの副作用を管理するための潜在的な治療標的を提供することを明らかにしています.
科学分野:
- 免疫学
- 腫瘍学
- 胃腸内科
背景:
- PD-1とCTLA-4受容体を標的とする免疫チェックポイント阻害剤は効果的ながん治療法です.
- 大腸炎のような重度の炎症性副作用は一般的ですが,その免疫的メカニズムは完全に理解されていません.
研究 の 目的:
- チェックポイント阻害誘発性大腸炎における免疫細胞集団を総合的に分析する.
- ガン免疫療法の重度の炎症的副作用を誘発するメカニズムを特定する.
主な方法:
- 大腸炎モデルにおける免疫細胞の単細胞分析
- T細胞受容体 (TCR) 配列分析により,細胞の起源を追跡する.
主要な成果:
- 高度な細胞毒性および増殖性CD8T細胞の蓄積が観察されました.
- 調節性T細胞減少の証拠は見つかりませんでした.
- 大腸炎に関連したCD8T細胞は,組織在住集団から発生することが示された.
結論:
- 大腸炎におけるCD8 T細胞の動態を理解することは,免疫療法による副作用の管理に極めて重要です.
- 特定されたサイトカイン,ケモカイン,および表面受容体は,大腸炎の治療標的として機能する.
- 組織に存在するT細胞は,大腸炎の早期発症に重要な役割を果たします.
関連する概念動画
Tumor Immunotherapy
1.6K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.6K
The Tumor Microenvironment
7.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.5K
Targeted Cancer Therapies
8.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.5K
The Intrinsic Apoptotic Pathway
7.9K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.9K
Cancer Vaccines
867
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
867
Cancer Therapies
9.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.7K


